Our three guests were: Svetlana Mojsov, who is a pioneer in the study of this crucial hormone and whose research has been instrumental in the development of GLP-1 receptor agonists Richard DiMarchi, whose academic expertise and work within the pharmaceutical industry has played a pivotal role in advancing both the scientific understanding and clinical application of GLP-1 therapies Stefan Trapp, who leads a research group that investigates the physiological functions of GLP-1 and its potential as a therapeutic target for metabolic diseases Speakers Svetlana Mojsov Svetlana Mojsov is a research associate professor at Rockefeller University, US
The result of that balance shift would be bone building
Ultimately, a single pill or supplement is just one tool
Novo Nordisk first won approval for an oral semaglutide, sold under the brand name Rybelsus, in 2019 to treat type 2 diabetes
Lets face it, wed all like enhanced fat burning, better wound healing, smoother skin, better blood pressure, sexual energy, slowed aging, reversed bone loss
Protein intake during a Retatrutide protocol matters more than most people realize going in
